"The Indian pharmaceutical market for chronic diseases is experiencing significant growth. By leveraging our expertise in chronic therapies and dedication to innovation and brand development, JB Pharma is well-positioned to continue its upward trajectory in the Indian pharmaceutical market." - Dilip Singh Rathore, President-India Business, JB Pharma
Read MoreTechnology, skills and learnings are industry-agnostic. It's your mindset that enables the implementation of a basic idea from one industry into something revolutionary in another says Priyanka
Read MoreEstablished in 2011 as a 50:50 joint venture for pharmaceutical sales and marketing in India, Bayer has now acquired the remaining 25 per cent stake to secure full ownership of the entity, in accordance with pre-agreed joint venture terms
Read MoreThe ‘Cure and Beyond’ campaign not only aims to spotlight innovation as the cornerstone of Emcure's operations but also endeavors to instill a sense of thought leadership within the Indian pharmaceutical sector
Read More